Dr. Jessica Grossman is the CEO of Medicines360, a 501(c)(3) nonprofit global women’s health pharmaceutical company with a mission to expand access to quality medicines for all women regardless of their socioeconomic status, insurance coverage or geographic location. Dr. Grossman is a seasoned industry executive and serial entrepreneur with a proven track record leading successful women’s health companies. Prior to joining Medicines360, she has founded Sense4Baby, Inc. and Gynesonics. Under her leadership, she invented and developed the first intrauterine ultrasound guided radio frequency ablation device for fibroid tumors. Dr. Grossman has performed research at the Beth Israel Deaconess Medical Center, one of the teaching hospitals of Harvard Medical School. In this episode we discuss increasing affordability and accessibility in women's health, equity in clinical studies and demystifying birth control.

Check out Medicines360 at medicines360.org

Rate, Review & Subscribe!